Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 655,267 | 262,518 | 257,837 | 19,959 | 33,392 |
| Marketable Securities | 428,612 | 110,904 | 153,756 | 189,111 | 149,601 |
| TOTAL | $1,092,101 | $380,563 | $419,320 | $215,848 | $189,136 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 0 | 54,863 |
| Intangibles | 19,918 | 19,918 | 19,918 | 19,918 | 19,918 |
| Other Non-Current Assets | 880 | 812 | 862 | 1,150 | 1,174 |
| TOTAL | $20,798 | $20,730 | $20,780 | $21,068 | $75,955 |
| Total Assets | $1,112,899 | $401,293 | $440,100 | $236,916 | $265,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,965 | 7,127 | 5,347 | 8,113 | 4,216 |
| Accrued Expenses | 37,222 | 24,514 | 20,446 | 19,028 | 14,797 |
| Other current liabilities | 113,017 | 49,471 | 40,905 | 38,275 | 18,944 |
| TOTAL | $157,204 | $81,112 | $66,698 | $65,416 | $37,957 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,467 | 40,773 | 40,579 | 40,385 | 41,191 |
| Other Non-Current Liabilities | 549 | 559 | 496 | 519 | 543 |
| TOTAL | $37,016 | $41,332 | $41,075 | $40,904 | $41,734 |
| Total Liabilities | $194,220 | $122,444 | $107,773 | $106,320 | $79,691 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,367 | 109,067 | 99,698 | 98,509 | 76,088 |
| Retained earnings | -818,756 | -659,770 | -582,672 | -532,236 | -464,971 |
| Other shareholders' equity | 417 | 824 | 1,085 | 1,001 | 807 |
| TOTAL | $918,679 | $278,849 | $332,327 | $130,596 | $185,400 |
| Total Liabilities And Equity | $1,112,899 | $401,293 | $440,100 | $236,916 | $265,091 |